Jun 01, 2020
Sumitovant Biopharma Announces Myovant Sciences' Submission of New Drug Application (NDA) to the FDA for Once-Daily Relugolix Combination Tablet for the Treatment of Women with Uterine Fibroids
May 13, 2020
Spirovant Sciences Appoints Roland Kolbeck, PhD, as Chief Scientific Officer
Apr 29, 2020
Sumitovant Biopharma Announces Publication of Myovant Abstracts Detailing Additional Efficacy and Safety Findings from Phase 3 Liberty Studies in Uterine Fibroids in Obstetrics & Gynecology
Apr 24, 2020
Sumitovant Biopharma Reports Key Clinical and Regulatory Milestones by Myovant Sciences
Mar 02, 2020
Altavant Sciences Appoints Respiratory Disease Medical Expert as Chief Medical Officer
Mar 02, 2020
Boston Biomedical, Inc. Announces Investment by its Parent Company in MPM Oncology Innovations Fund
Mar 02, 2020
Boston Biomedical, Inc. Announces Investment by its Parent Company in MPM Oncology Innovations Fund
Jan 08, 2020
Roivant Sciences to Present at the 38th Annual J.P. Morgan Healthcare Conference
Dec 30, 2019
Sumitovant Biopharma Created and Launched as Sumitomo Dainippon Pharma and Roivant Sciences Close Transaction for Strategic Alliance
Dec 03, 2019
Boston Biomedical, Inc. Enters into an Alliance in Oncology Research with Columbia University, Harvard University and The Wistar Institute
Dec 03, 2019
Sumitomo Dainippon Pharma Becomes a Global Partner to Plug and Play's Innovation Platform
Oct 29, 2019
Tolero Pharmaceuticals Presents Findings from Preclinical Studies Evaluating Investigational Agents TP-1287 in Prostate Cancer Models and TP-1454 in Colorectal Cancer Models
Sep 05, 2019
Sumitomo Dainippon Pharma and Roivant Sciences Enter into a Memorandum of Understanding to Create Broad Strategic Alliance to Deliver Promising New Medicines to Patients
Jul 24, 2019
Drawbridge Health Announces Strategic International Financing To Accelerate Blood Sampling Technology Innovation
Jan 31, 2019
Global Large Volume Wearable Injectors Market, 2018-2030: Current Market Landscape and the Likely Future Evolution of Self-Injection Devices
Jan 24, 2019
Visiongain Report Looks at Opportunities within the $47bn Asthma & COPD Market
Jul 11, 2018
Sumitomo Dainippon Pharma Chooses SciFinder(n) from CAS to Enhance Research Productivity and Accelerate Growth
Jun 22, 2018
Global CNS Therapeutics Markets, 2024: Awareness Campaigns Launched by Pharma Companies to Benefit the Market
Apr 03, 2018
Sumitomo Dainippon Pharma Co. Ltd. Chooses Cytonome's GigaSort® Cell Sorting Technology for Cell Bioprocessing
Nov 21, 2017
Sumitomo Dainippon Pharma and Angelini Announce Partnership for Commercialization of Latuda(R) (Lurasidone Hydrochloride) in Europe